(Hypertension. 1997;30:416.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Pharmacology and Toxicology, Queens University, Kingston, Ontario, Canada (J.D.B., K.E.T., M.A.A.); and the Department of Physiology, Göteborg University, Göteborg, Sweden (P.F.).
Abstract The goal of the present study was to
characterize the activation profile of the growth-related enzyme
ornithine decarboxylase (ODC) in cardiovascular tissue
during hypertension induced by chronic NO synthase blockade in relation
to the development of structurally based changes in the heart and blood
vessels. In previously instrumented conscious rats, mean
arterial pressure and ODC activation were measured in
cardiovascular tissue of rats treated with
N
-nitro-L-arginine methyl ester
(L-NAME; 100 mg/kg per day PO) for 4 hours and 1, 6, and 12 days. After
12 days of L-NAME treatment alone or in combination with 3%
L-ornithine, structurally based hindlimb resistance properties were
assessed. A marginal activation of ODC in the left ventricle and aorta
was seen at 4 hours but returned to control levels at 1, 6, and 12 days
of L-NAME treatment. A slightly prolonged yet transient activation of
ODC occurred in the mesenteric vascular bed. Structurally based
hindlimb vascular resistance was enhanced by 15% at maximum
vasoconstrictor tone, and no change in cardiac mass occurred with
L-NAME treatment. L-NAME+3% L-ornithine treatment resulted in a
similar level of structural upregulation compared with L-NAME treatment
alone. In summary, 12 days of L-NAME treatment resulted in only a
modest change in vascular resistance, and only at maximum constriction,
and no cardiac hypertrophy despite the presence of marked
hypertension. The results of the present study indicate that either
(1) pressure alone is not a sufficient stimulus to induce
cardiovascular growth processes or (2) L-NAME may be
"nonspecifically" inhibiting cardiovascular
growth processes.
Key Words: ornithine decarboxylase hypertension L-NAME hypertrophy
This article has been cited by other articles:
![]() |
T. M. Hale, M. J. Shoichet, T. L. Bushfield, and M. A. Adams Time Course of Vascular Structural Changes During and After Short-Term Antihypertensive Treatment Hypertension, August 1, 2003; 42(2): 171 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsunaga, D. C. Warltier, D. W. Weihrauch, M. Moniz, J. Tessmer, and W. M. Chilian Ischemia-Induced Coronary Collateral Growth Is Dependent on Vascular Endothelial Growth Factor and Nitric Oxide Circulation, December 19, 2000; 102(25): 3098 - 3103. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jolma, J. Kalliovalkama, J.-P. Tolvanen, P. Koobi, M. Kahonen, N. Hutri-Kahonen, X. Wu, and I. Porsti High-calcium diet enhances vasorelaxation in nitric oxide-deficient hypertension Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1036 - H1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kalliovalkama, P. Jolma, J.-P. Tolvanen, M. Kahonen, N. Hutri-Kahonen, X. Wu, P. Holm, and I. Porsti Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism Cardiovasc Res, June 1, 1999; 42(3): 773 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zatz and C. Baylis Chronic Nitric Oxide Inhibition Model Six Years On Hypertension, December 1, 1998; 32(6): 958 - 964. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |